{"id":551287,"date":"2026-04-01T22:50:07","date_gmt":"2026-04-01T20:50:07","guid":{"rendered":"https:\/\/medizinonline.com\/nuevos-estandares-terapeuticos-con-shr-a-1811\/"},"modified":"2026-04-01T22:50:42","modified_gmt":"2026-04-01T20:50:42","slug":"nuevos-estandares-terapeuticos-con-shr-a-1811","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/nuevos-estandares-terapeuticos-con-shr-a-1811\/","title":{"rendered":"Nuevos est\u00e1ndares terap\u00e9uticos con SHR-A 1811"},"content":{"rendered":"\n<p><strong>El Congreso ESMO 2025 de este a\u00f1o volvi\u00f3 a ofrecer un amplio abanico de nuevos datos sobre el tratamiento del c\u00e1ncer de mama HER2-positivo, incluido el an\u00e1lisis provisional del estudio de fase 3 HORIZON-Breast01 presentado por Erwei Song (Universidad Sun Yat-sen, Guangzhou). El estudio compara el SHR-A 1811 con pirotinib m\u00e1s capecitabina en pacientes con c\u00e1ncer de mama metast\u00e1sico HER2-positivo. Proporciona los primeros datos aleatorizados sobre este nuevo conjugado anticuerpo-f\u00e1rmaco dirigido al HER2.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fnuevos-estandares-terapeuticos-con-shr-a-1811%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>El Congreso ESMO 2025 de este a\u00f1o volvi\u00f3 a ofrecer un amplio abanico de nuevos datos sobre el tratamiento del c\u00e1ncer de mama HER2-positivo, incluido el an\u00e1lisis provisional del estudio&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fnuevos-estandares-terapeuticos-con-shr-a-1811%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":551290,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"C\u00e1ncer de mama HER2+ con met\u00e1stasis  ","footnotes":""},"category":[11483,11475,11369,11336,11552],"tags":[90079,13548,90077,17405,90090,22447,90071,90073,90083,90080,90075,90067,90069,90084,90068,90088],"powerkit_post_featured":[],"class_list":["post-551287","post","type-post","status-publish","format-standard","has-post-thumbnail","category-el-congreso-informa","category-estudios","category-ginecologia","category-oncologia","category-rx-es","tag-analisis-provisional-estudio-de-fase-3-horizon-breast01","tag-cancer-de-mama","tag-cancer-de-mama-metastasico-her2-positivo","tag-capecitabina-es","tag-congreso-esmo-2025","tag-esmo-es","tag-estudio-de-fase-1-horizon-x","tag-estudio-pehdra","tag-estudio-phoebe","tag-nuevos-conjugados-anticuerpo-farmaco-dirigidos-contra-her2","tag-perfil-de-efectos-secundarios-shr-a-1811-frente-a-pirotinib-capecitabina","tag-pirotinib","tag-pirotinib-mas-capecitabina","tag-secuenciacion-de-terapias-dirigidas-al-her2","tag-shr-a-1811","tag-shr-a1811-trastuzumab-rezetecan","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-21 18:50:03","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/551287","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=551287"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/551287\/revisions"}],"predecessor-version":[{"id":551291,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/551287\/revisions\/551291"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/551290"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=551287"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=551287"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=551287"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=551287"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}